Non-inferiority margin red flags
6:49–8:07 · 78s
Guest Dr. Shani Herzig dissects the CHAMPION AF trial, arguing the chosen 4.8% non-inferiority margin could mask clinically meaningful increases in stroke and bias the trial toward a positive result.
6:49–8:07 · 78s
Guest Dr. Shani Herzig dissects the CHAMPION AF trial, arguing the chosen 4.8% non-inferiority margin could mask clinically meaningful increases in stroke and bias the trial toward a positive result.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.